SF
Seamus Fernandez Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
32
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
89.5%
Neutral
10.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $35 |
48%
upside
| 2 | +27% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Buy
Maintained
| $143 |
60%
upside
| 3 | +1.8% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Buy
Maintained
| $72 |
18%
upside
| 2 | +9.6% |
0
%
| 6 Feb ‘26 26 days ago |
|
|
|
Buy
Initiated
| $27 |
380%
upside
| 1 | -9.8% |
0
%
| 3 Feb ‘26 29 days ago |
|
|
|
Buy
Reiterated
| $116 |
94%
upside
| 2 | -5.8% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $1,161 |
15%
upside
| 7 | +5.9% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $140 |
122%
upside
| 2 | +207% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $88 |
188%
upside
| 4 | +69% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $25 |
119%
upside
| 2 | +46% |
0
%
| 17 Dec ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 9 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $11 |
81%
upside
| 1 | +50% |
0
%
| 18 Nov ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| – | – | 5 | +92% |
0
%
| 18 Nov ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | – |
–
| 23 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $25 |
77%
upside
| 2 | +77% |
0
%
| 15 Sep ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $116 |
69%
upside
| 1 | +55% |
0
%
| 2 Jul ‘25 8 months ago |
|
|
|
Buy
Reiterated
| – | – | 1 | +92% |
0
%
| 25 Mar ‘25 11 months ago |
|